Tentarix Biotherapeutics

Tentarix Biotherapeutics is a biotech company in San Diego, United States, founded in 2020. It has raised $85.0M across 2 rounds, most recently a $35.0M Series B in September 2023.

Conditionally Active Biologics

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$85.0M
Last Round
$35.0M Series BSep 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

Tentarix Biotherapeutics develops conditionally active multispecific biologics designed to reach difficult-to-treat targets with a high therapeutic index. Its platform combines stabilized fully human binders with screening that identifies molecules whose activation is restricted to targeted cells. The company applies these technologies to therapies in oncology, including immuno-oncology, and autoimmune disease.

Summary

It lists 11–50 employees. It has raised $85.0M in total across 2 rounds, most recently a $35.0M Series B round in Sep 2023.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BSep 2023
$35.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tentarix Biotherapeutics on Indexed.vc
<a href="https://indexed.vc/companies/tentarix-biotherapeutics"><img src="https://indexed.vc/api/badge/company/tentarix-biotherapeutics" alt="Tentarix Biotherapeutics on Indexed.vc" width="260" height="76" /></a>